2005 Annual Meeting | Pain Management: Principles and Practice

Date Saturday 04/16/05

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Richard Payne, MD

Topic(s) Headache/Other Pain Syndromes

Learning Objectives Upon completion:
Participants should be familiar with the latest concepts in pain modulation and the evidence linking chronic analgesic use with hyperalgesia and persistent pain, and become familiar with the most recent evidence supporting the use of specific drugs in neuropathic pain.

The American Board of Psychiatry and Neurology has reviewed Pain Management: Principles and Practice and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident

Event Timeline
09:00 AM - 09:45 AM		Why Should the Neurologist Deal with Pain? Charles E. Argoff, MD
09:45 AM - 10:30 AM		Neuropathic Pain and the Neurologist Misha-Miroslav Backonja, MD
10:30 AM - 11:15 AM		Concepts in Opiod Analgesia/Paradoxical Affects of Opioid Antagonists Ricardo Cruciani, MD
11:15 AM - 11:30 AM		Break
11:30 AM - 12:15 PM		Recent Issues in Cancer Pain Richard Payne, MD
12:15 PM - 12:45 PM		Discussion

Faculty Disclosures
Richard Payne, MD	No disclosure on file
Charles E. Argoff, MD	Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for XGene. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Colllegium. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Argoff has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Scilex. The institution of Dr. Argoff has received research support from Lilly. The institution of Dr. Argoff has received research support from Lundbeck. The institution of Dr. Argoff has received research support from Abbvie. The institution of Dr. Argoff has received research support from Vertex. Dr. Argoff has received publishing royalties from a publication relating to health care.
Misha-Miroslav Backonja, MD	Dr. Backonja has nothing to disclose.
Ricardo Cruciani, MD	No disclosure on file

��ɫ��

��ɫ��